Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion type Assertion NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_head.
- NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion wasGeneratedBy ECO_0000203 NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_provenance.
- NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion wasDerivedFrom befree-20150227 NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_provenance.
- NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion SIO_000772 24312355 NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_provenance.
- NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion evidence source_evidence_literature NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_provenance.
- NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_assertion description "[Recently, inhibition of the mammalian target of rapamycin (mTOR) has been shown to alleviate cardinal asthmatic features, including airway hyperresponsiveness, eosinophilic inflammation, and increased vascular permeability in asthma models.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP411706.RAjMeGaYT7P0KwKtNEPGpogJxZjifA5eUsnsaxIoxFPlo130_provenance.